Nobuo

Results: 135



#Item
21

Kyowa Hakko Kirin Enters Option Agreement with AstraZeneca for Commercialisation of Benralizumab (KHK4563) in Japan Tokyo, Japan, July 16th, 2015—Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai

Add to Reading List

Source URL: www.kyowa-kirin.com

Language: English - Date: 2015-07-21 21:00:16
    22

    FOR IMMEDIATE RELEASE March 10, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Officer

    Add to Reading List

    Source URL: www.kyowa-kirin.com

    Language: English - Date: 2014-03-10 00:10:04
      23

      Kyowa Hakko Kirin and AstraZeneca Partner on Immuno-Oncology Clinical Study Tokyo, Japan, July 30, Kyowa Hakko Kirin Co., Ltd. (Tokyo; 4151 President and CEO: Nobuo Hanai; "Kyowa Hakko Kirin") announced today th

      Add to Reading List

      Source URL: www.kyowa-kirin.com

      Language: English - Date: 2014-07-30 01:30:04
        24

        Approval of REGPARA® Tablets 12.5mg in Japan Tokyo, Japan, February 16, 2015—Kyowa Hakko Kirin Co., Ltd. (Tokyo: 4151, President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) announced today that REGPARA® Tablets 12

        Add to Reading List

        Source URL: www.kyowa-kirin.com

        Language: English - Date: 2015-02-16 00:00:17
          25

          FOR IMMEDIATE RELEASE Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE) Inquiries: Shigeru Morotomi, Executive Officer Corporate Commun

          Add to Reading List

          Source URL: www.kyowa-kirin.com

          Language: English - Date: 2015-07-24 02:00:04
            26

            FOR IMMEDIATE RELEASE February 17, 2015 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Offi

            Add to Reading List

            Source URL: www.kyowa-kirin.com

            Language: English - Date: 2015-02-17 02:40:04
              27

              FOR IMMEDIATE RELEASE Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Officer

              Add to Reading List

              Source URL: www.kyowa-kirin.com

              Language: English - Date: 2014-02-19 02:10:04
                28

                FOR IMMEDIATE RELEASE Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Officer Corporate Comm

                Add to Reading List

                Source URL: www.kyowa-kirin.com

                Language: English - Date: 2014-02-19 02:10:04
                  29

                  FOR IMMEDIATE RELEASE March 20, 2014 Listed Company Name: Kyowa Hakko Kirin Co., Ltd. Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of Tokyo) Inquiries: Shigeru Morotomi, Executive Officer

                  Add to Reading List

                  Source URL: www.kyowa-kirin.com

                  Language: English - Date: 2014-03-20 02:40:04
                    30

                    Launch of Dovobet® Ointment Topical Combination Drug for Psoriasis Vulgaris Tokyo, Japan, September 11, Kyowa Hakko Kirin Co., Ltd. (headquarters: Chiyoda-ku, Tokyo; President and CEO: Nobuo Hanai; “Kyowa Hakk

                    Add to Reading List

                    Source URL: www.kyowa-kirin.com

                    Language: English - Date: 2014-09-11 01:00:04
                      UPDATE